1. Home
  2. CHT vs TEVA Comparison

CHT vs TEVA Comparison

Compare CHT & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chunghwa Telecom Co. Ltd.

CHT

Chunghwa Telecom Co. Ltd.

HOLD

Current Price

$45.37

Market Cap

34.5B

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$38.89

Market Cap

40.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHT
TEVA
Founded
1996
1901
Country
Taiwan
Israel
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.5B
40.5B
IPO Year
2003
1996

Fundamental Metrics

Financial Performance
Metric
CHT
TEVA
Price
$45.37
$38.89
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$38.63
AVG Volume (30 Days)
175.9K
4.1M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
3.02%
N/A
EPS Growth
N/A
183.45
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.37
N/A
Revenue Next Year
$3.23
$2.97
P/E Ratio
$26.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.28
$18.21
52 Week High
$46.48
$38.37

Technical Indicators

Market Signals
Indicator
CHT
TEVA
Relative Strength Index (RSI) 78.34 57.51
Support Level $41.90 $30.42
Resistance Level $45.10 $38.37
Average True Range (ATR) 0.42 1.04
MACD 0.19 -0.12
Stochastic Oscillator 96.92 64.75

Price Performance

Historical Comparison
CHT
TEVA

About CHT Chunghwa Telecom Co. Ltd.

Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company's reportable segments are: Consumer Business, Enterprise Business, International Business, and Others. The majority of its revenue comes from the Consumer Business, which focuses on individual and home-centric businesses, such as mobile, fixed broadband, Wi-Fi, IPTV (MOD), and OTT services. The Enterprise business offers IDC, cloud, cybersecurity, 5G, AIoT, data, AI, enterprise digital transformation, and system integration services to businesses, and the International business segment represents services offered to international customers. Geographically, the company generates maximum revenue from its business in Taiwan.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: